NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

Teleflex Incorporated (TFX) Stock Analysis

Teleflex Incorporated (TFX) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

TFX

$130.40

−$0.75 (−0.57%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare TFX with… →

TFX Key Statistics

As of Oct 21, 2026
Trading
Open
$130.61
Previous Close
$131.15
Day's Range
129.41–132.16
52-Week Range
100.18–145.00
Volume
400.45K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.83
Valuation
Market Cap
$5.53B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
11.92
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.16
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.45
EPS (ttm)Profit attributable to each share over the last twelve months.
−8.48
Financials (FY)
Revenue (FY)
$1.99B+17.25%
Net Income (FY)
−$905.64M−1,399.81%
Profit marginThe share of revenue left as profit after all costs and taxes.
−45.76%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
42.37M
1-Year Return
−1.15%
Dividend and dates
Dividend
$1.36+1.04%
Ex-Dividend Date
August 14, 2026
Earnings Date
October 29, 2026
Avg Volume
693.63K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, TFX closed at $130.40, −1.15% over 1 year.

Teleflex Incorporated (TFX) has a market capitalization of $5.53B.

In fiscal 2025, TFX reported revenue of $1.99B.

TFX Stock Return by Calendar Year

Teleflex Incorporated (TFX) 10-year return: what $10,000 became

1 year
$10,000 $9,885
−1.15%
5 years
$10,000 $3,570
−64.30%
10 years
$10,000 $8,253
−17.47%

If you had invested $10,000 in Teleflex Incorporated (TFX) 10 years ago, at the close on October 21, 2016, it would have been worth $8,253 at the close on October 21, 2026: −17.47% in total, −1.90% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+7.44%
2025−30.67%
2024−28.16%
2023+0.48%
2022−23.61%
2021−19.89%
2020+9.75%
2019+46.26%
2018+4.45%
2017+55.41%
2016 (partial year)−9.73%

As of October 21, 2026.

TFX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.99B−$905.64M−45.4%
2024$1.70B$69.68M4.1%
2023$1.71B$356.33M20.8%
2022$2.79B$363.14M13.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.99B$1.12B$255.80M−$905.64M−45.4%
2024$1.70B$1.04B$253.85M$69.68M4.1%
2023$1.71B$1.04B$303.75M$356.33M20.8%
2022$2.79B$1.53B$513.52M$363.14M13.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

TFX Dividend History

$1.36+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.023—
2025$1.364+0.0%
2024$1.364+0.0%
2023$1.364+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)$1.023—
2025$1.364+0.0%
2024$1.364+0.0%
2023$1.364+0.0%
2022$1.364+0.0%
2021$1.364+0.0%
2020$1.364+0.0%
2019$1.364+0.0%
2018$1.364+0.0%
2017$1.364+300.0%
2016$0.341—

Most recent payment: $0.34 per share, ex-dividend August 14, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

TFX Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricTFXMedical Instruments & Supplies medianvs median
P/S ratio2.452.606% below
Profit margin−45.76%1.62%47.4 pts below

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Teleflex Incorporated (TFX) at $5.53B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 15,500.

The most recent close on file for TFX is $130.40, dated October 21, 2026. That is −$0.75 (−0.57%) against the previous close. The 52-week range on file runs from $100.18 to $145.00. The latest close sits 30.17% above that 52-week low.

Financial Health

In fiscal 2025, Teleflex Incorporated reported revenue of $1.99B. That is +17.25% against the prior fiscal year, when revenue was $1.70B. The same year closed with a net loss of $905.64M. Profit margin runs at −45.76%. That is 47.4 percentage points below the Medical Instruments & Supplies median of 1.62%. Trailing earnings per share are −8.48.

Across the 4 fiscal years on file, revenue moves from $2.79B in 2022 to $1.99B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 11.92. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.16. The price-to-sales ratio is 2.45. On price-to-sales that is 5.66% below the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.83. Annualized volatility over the trailing 10 years is 32.47%. Over the trailing twelve months the total return is −1.15%. Measured over 10 years, that is −1.90% a year compounded.

Growth & Income

The trailing dividend yield is 1.04%. The indicated annual rate is $1.36 a share. The ex-dividend date on file is August 14, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.02 a share. The year before, 2025, totalled $1.36 a share.

The strongest complete calendar year on file is 2017 at +55.41%; the weakest is 2025 at −30.67%. Of the 9 complete calendar years on file, 5 finished higher. So far in 2026 the total return is +7.44%.

Peer Comparison

Teleflex Incorporated (TFX) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Teleflex Incorporated TFX $5.53B —
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Teleflex Incorporated has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Visit website →